iFR: Proven outcomes. Superior value.

Philips is dedicated to the advancement of physiology guided PCI. Since the introduction of hyperemia-free iFR modality in 2014, iFR has been studied in nearly 15,000 patients and used in over 4,000 cath labs around the world.

 

D041511-00